Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent

Recently, new therapeutics have been developed for hepatocellular carcinoma (HCC). However, the overall survival rate of HCC patients is still unsatisfactory; one of the reasons for this is the high frequency of recurrence after radical treatment. Consequently, to improve prognosis, it will be impor...

Descripción completa

Detalles Bibliográficos
Autores principales: Enjoji, Munechika, Watase, Daisuke, Matsunaga, Kazuhisa, Kusuda, Mariko, Nagata-Akaho, Nami, Karube, Yoshiharu, Takata, Jiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548248/
https://www.ncbi.nlm.nih.gov/pubmed/28943616
http://dx.doi.org/10.3390/diseases3030150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548248/
https://www.ncbi.nlm.nih.gov/pubmed/28943616
http://dx.doi.org/10.3390/diseases3030150

Ejemplares similares